University of California, San Francisco-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2017

  1. A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis

    Kidney International Reports, Vol. 2, Núm. 5, pp. 800-810